CTOs on the Move

Ovid Therapeutics

www.ovidrx.com

 
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ovidrx.com
  • 1460 Broadway
    New York, NY USA 10036
  • Phone: 646.661.7661

Executives

Name Title Contact Details
Stephanie Licata
 VP, Program Leadership & Portfolio Management Profile

Funding

Ovid Therapeutics raised $75M on 08/11/2015
Ovid Therapeutics raised $25.86M on 01/23/2017
Ovid Therapeutics raised $25M on 02/26/2019
Ovid Therapeutics raised $20M on 02/26/2019

Similar Companies

Rush-Copley Medical Center, Inc

Rush-Copley Medical Center, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Aurora, IL. To find more information about Rush-Copley Medical Center, Inc, please visit www.rushcopley.com

Consulmed

Consulmed LLC is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Consulmed LLC is based in Bountiful, UT. You can find more information on Consulmed LLC at www.consulmed.com

Diederich Insurance Agency

Diederich Insurance Agency LLC is a Carbondale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Johnson Health Tech. Co.

Cardio-Respiratory Assistance

Cardio-Respiratory Assistance is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.